• Thirty-two cases of sudden, symmetrical, high-frequency, sensorineural hearing loss associated with intravenous (IV) and oral erythromycin therapy have been published since 1973. We treated a patient with reversible ototoxicity associated with IV erythromycin for the treatment of legionnaire's disease.
(Arch Otolaryngol 1984;110:258-260)
Schweitzer VG, Olson NR. Ototoxic Effect of Erythromycin Therapy. Arch Otolaryngol. 1984;110(4):258–260. doi:10.1001/archotol.1984.00800300050011
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: